CRP and hydrops fetalis: These findings underscore the clinical imperative for preemptive biomarker monitoring (e.g., quarterly HbA1c/CRP tracking) and stratified interventions, such as intensified volume management in elderly patients or anti-inflammatory protocols for those with persistent CRP elevation, to disrupt the HF trajectory.